Forum Financial Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Hold
24,118
﹤0.01% 334
2026
Q1
$42.4K Sell
24,118
-16,080
-40% -$34.9K ﹤0.01% 323
2025
Q4
$94.5K Buy
40,198
+2,961
+8% +$8.09K ﹤0.01% 995
2025
Q3
$114K Buy
37,237
+2,990
+9% +$8.54K ﹤0.01% 992
2025
Q2
$95.5K Buy
34,247
+18,170
+113% +$59.7K ﹤0.01% 934
2025
Q1
$57.7K Hold
16,077
﹤0.01% 858
2024
Q4
$50.6K Hold
16,077
﹤0.01% 885
2024
Q3
$45.3K Buy
16,077
+4,061
+34% +$9.3K ﹤0.01% 763
2024
Q2
$14.8K Hold
12,016
﹤0.01% 714
2024
Q1
$9.54K Hold
12,016
﹤0.01% 741
2023
Q4
$11.4K Hold
12,016
﹤0.01% 687
2023
Q3
$13K Hold
12,016
﹤0.01% 640
2023
Q2
$10.8K Hold
12,016
﹤0.01% 659
2023
Q1
$10.2K Hold
12,016
﹤0.01% 620
2022
Q4
$11.2K Sell
12,016
-150
-1% -$200 ﹤0.01% 594
2022
Q3
$21K Hold
12,166
﹤0.01% 540
2022
Q2
$26K Hold
12,166
﹤0.01% 573
2022
Q1
$43K Buy
+12,166
New +$35.3K ﹤0.01% 606

Other funds holding CLOV

Forum Financial Management's CLOV Position: Q2 2026 in Review

Forum Financial Management held its Clover Health Investments (CLOV) position steady in Q2 2026 at 24,118 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #334.

Forum Financial Management first reported a position in CLOV in Q1 2022 and has held it in 18 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Forum Financial Management held 24,118 shares of Clover Health Investments worth $126K as of Q2 2026.
  • Forum Financial Management left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of Forum Financial Management's portfolio in Q2 2026, its #334 holding.
  • Forum Financial Management first reported a position in Clover Health Investments in Q1 2022 and has held it in 18 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Forum Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.